Purple urine bag syndrome in a long-term care resident Authors: Hiroaki Nishioka Published: 2026 An 88-year-old woman with mild dementia who resided in a long-term care (LTC) facility developed urinary retention. An indwelling Foley catheter was placed. Her medical history included chronic constipation without documented recurrent urinary tract infections or urinary tract abnormalities. Two weeks later, an intense purple discoloration developed in the catheter and urinary drainage bag (Figure 1). The patient was afebrile, with normal vital signs and no alterations in mental status. The urine within the catheter remained yellow, with pigment adhering only to the synthetic surfaces. Given the lack of clinical indicators of urinary tract infection, urine analysis was deferred. Purple urine bag syndrome (PUBS) was diagnosed. The catheter and bag were exchanged without initiating antimicrobial therapy, and bowel management was optimized. The discoloration resolved promptly and did not recur. Purple discoloration of an indwelling Foley catheter and drainage bag, with preserved yellow coloration of the urine of a 88-year-old woman. Purple urine bag syndrome is a benign condition resulting from microbial metabolism of tryptophan into indigo and indirubin pigments that adhere to the catheter and bag surfaces, producing a purple coloration.1,2 Risk factors include long-term urinary catheterization, advanced age, female sex, constipation, alkaline urine, residence in an LTC facility, and intestinal intussusception. 2 Commonly implicated organisms include Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, Enterococcus species, and Pseudomonas aeruginosa.2,3 Although PUBS is a benign visual phenomenon, it is often associated with bacteriuria and may coexist with symptomatic urinary tract infections. In asymptomatic patients, recognizing that the urine itself remains yellow can prevent unnecessary testing and antibiotic administration. Diagnostic testing and antimicrobial therapy are required if fever, systemic signs of infection, urinary symptoms, or changes in mental status occur. Other causes of abnormal urine discoloration include medications (e.g., orange urine with rifampin, green urine with propofol, amitriptyline, or methylene blue), and metabolic conditions (e.g., reddish-brown urine in porphyria, darkening urine in alkaptonuria). Contributing factors such as constipation should be addressed. Recognition of PUBS can help prevent unnecessary antibiotic use in asymptomatic patients. Acknowledgement The author used Editage (www.editage.jp) for English language editing. Footnotes Competing interests: None declared. This article has been peer reviewed. The authors have obtained patient consent. References